Skip to main content
ARS Home » News & Events » News Articles » Research News » 1999 » Making Coccidia Less Cocky

Archived Page

This page has been archived and is being provided for reference purposes only. The page is no longer being updated, and therefore, links on the page may be invalid.

Making Coccidia Less Cocky

By Judy McBride
February 19, 1999

Coccidiosis--among the top five diseases preventing weight gain in chickens--is under serious attack at two Agricultural Research Service laboratories in Beltsville, Md. A handful of ARS researchers are working with companies to develop treatments that will use the birds' own immunity against the coccidia protozoa.

Worldwide, coccidiosis costs producers some $600 million. And the problem could worsen; the protozoa are developing drug resistance.

To give producers temporary relief, the researchers developed and tested a gamma-irradiated vaccine. Mark Jenkins of ARS' Immunology and Disease Resistance Laboratory determined the radiation dose needed to weaken the live oocysts--the infectious stage of coccidia. This prevents them from reproducing and stimulates the birds' immunity.

Harry Danforth of the Parasite Biology and Epidemiology Laboratory tested the vaccine on Cornish hens at Perdue Farms, Inc., in Salisbury, Md. It reduced the amount of feed needed to raise a Cornish hen by 3 hundredths of a pound. This may seem insignificant, but could save $1 million annually in feed costs for Perdue's Cornish hens alone--and much, much more in the broiler industry.

The trouble is, the new vaccine isn't a feasible long-term solution because it requires too many oocysts, which must be grown in live chickens. Potentially more permanent controls include:

Scientific contact: Harry Danforth, ARS Parasite Biology and Epidemiology Laboratory, Beltsville, Md., phone (301) 504-8300, fax (301) 504-6273; Mark Jenkins or Hyun Lillehoj, ARS Immunology and Disease Resistance Laboratory, Beltsville, Md., phone (301) 504-8201; fax (301) 504-5306,;;